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Human Papillomavirus in Squamous Cell Carcinoma
Asgari et al. examined human papillomavirus 
(HPV) prevalence in tissue samples from 85 
immunocompetent patients with histologically 
confirmed squamous cell carcinomas (SCCs) 
and 95 age-matched controls without skin 
cancer history. The overall HPV DNA detec-
tion rate was high in case lesions (54%) and 
perilesions (50%) and in both sun-exposed 
normal tissue (59%) and non-sun-exposed nor-
mal tissue (49%) from controls. A high HPV 
DNA prevalence among controls indicates that 
HPV DNA is widely distributed among the general population, whereas the differen-
tial detection of HPV β-papillomavirus species 2 in tumors suggests that certain HPV 
types may be involved in the progression of cutaneous SCC. See page 1409
Catestatin, an Inducible Antimicrobial Peptide
Radek et al. studied catestatin (Cst), a pep-
tide derived from the neuroendocrine pro-
tein chromogranin A (CHGA), and found 
it to be present in the epidermis and to 
have functional antimicrobial properties 
against an assortment of skin pathogens. 
CHGA was expressed in keratinocytes 
and was proteolytically processed into 
the antimicrobial fragment Cst, enabling 
its antimicrobial function. In addition, Cst 
expression in murine skin increased in response to injury and infection. The data dem-
onstrate a direct neuroendocrine–cutaneous immune link. See page 1525
Gene Transfer Strategies for Skin Repair
Escámez et al. used a skin-humanized mouse model to identify an optimal, clini-
cally viable growth-factor delivery system for wound healing. The three approaches 
included keratinocyte growth factor (KGF) gene transfer by (1) intradermal adenoviral 
injection, (2) adenoviral vector immobilized in a fibrin carrier, and (3) KGF–adenovi-
ral gene–transferred human fibroblasts embedded in a fibrin matrix. All of the deliv-
ery systems achieved KGF protein overproduction in wound sites with enhanced re- 
epithelialization, but the genetically modified fibroblast-containing matrix used as an 
in situ protein bioreactor was highly reproducible, leading to a significant improve-
ment of the overall healing process. See page 1565
NKT Cells in Allergic 
Contact Dermatitis
To identify invariant natural 
killer T cells (NKT cells) and 
the cytokines associated with 
allergic contact dermatitis, 
Gober et al. took skin biopsy 
specimens from positive patch 
test reactions of 10 patients (nine 
different allergens). Invariant 
NKT cells were identified in 
all 10 skin biopsy specimens 
studied, ranging from 1.72% 
to 33% of the cellular infiltrate. 
These NKT cells were activated 
in all cases, as demonstrated by 
cytokine transcript expression of 
IFN-γ and IL-4. The researchers 
concluded that NKT cells are 
constantly present during 
the late elicitation phase of 
human type IV hypersensitivity 
reactions. See page 1460
The Filaggrin Gene 
and Nickel Allergy
To assess the relationship 
between the filaggrin (FLG) gene 
and allergic contact sensitization, 
Novak et al. performed 
dermatologic phenotyping of the 
two prevalent FLG mutations—
R501X and 2282del4—in 1,502 
individuals. Associations of FLG 
mutations with atopic eczema 
could be replicated and strongly 
associated with dry skin, palmar 
hyperlinearity, and keratosis 
pilaris. Contact sensitization to 
nickel and to nickel combined 
with jewelry intolerance, but 
not with other contact allergens, 
was also implicated. The 
investigators concluded that 
a genetically determined FLG 
deficiency manifests as dry skin 
and ichthyosis vulgaris features 
and that such a deficiency may 
be a risk factor for contact 
sensitization to allergens. See 
page 1430
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